Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000899140-24-000596
Filing Date
2024-05-14
Accepted
2024-05-14 13:29:40
Documents
1
Effectiveness Date
2024-05-14
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8690
  Complete submission text file 0000899140-24-000596.txt   9797
Mailing Address 375 PARK AVENUE NEW YORK NY 10152
Business Address 375 PARK AVENUE NEW YORK NY 10152 212-751-5959
EP Life Sciences L.P. (Filer) CIK: 0001744892 (see all company filings)

EIN.: 830584171 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-315695 | Film No.: 24942744